- Meeting abstract
- Open Access
Preliminary experience in pulmonary metastatectomy
© Sersar and Yassin 2015
- Published: 16 December 2015
- Survival Rate
- Colorectal Cancer
- Retrospective Study
- Lung Metastasis
- Resected Specimen
The surgical resection of pulmonary metastasis is not new it dates back to 1994 thanks to Blalock who resected lung metastases from colorectal cancer. He reported his preliminary results in 1947. Since then, there is a wide variation in the 5-year survival rate achieved by lung metastatectomies in different institutions. It varies between 9% to 45%.
We aimed to review our preliminary limited experience in pulmonary metastatectomies in KAMC; Makkah; Saudi Arabia in more than 3 years.
This is a retrospective study including 21 patients who had pulmonary metastatectomy in KAMC; Makkah between 2012 January and June 2015.
Our study included 21 patients who had lung metastases and were operated upon by thoracic surgeons. Females constituted more than 2/3 of this series. Mean age was 26 years. Mean follow up duration was 25 months. The commonest primary originated from the bones and rectosigmoid. Thirty five thoracic surgeries were required for those 21 cases. Twelve patients had one thoracic surgery, five had 2 surgeries, three had 3 surgeries and one had 4 surgeries. We used either VATS or thoracotomy in our lung metastatectomies. Only one third of the resected specimens were proved to be metastatic. No significant perioperative complications were reported in our series. No mortality was reported during the study period.
Pulmonary metastatectomy can be performed safely either by VATS or through thoracotomy with acceptable results.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.